Contribution and performance of multimodal imaging in the diagnosis and management of cardiac masses.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
May 2020
Historique:
received: 18 10 2019
accepted: 09 01 2020
pubmed: 11 2 2020
medline: 8 9 2020
entrez: 11 2 2020
Statut: ppublish

Résumé

To evaluate the contribution and performance of multimodal imaging in the diagnostic and therapeutic management of cardiac masses. We carried out a monocentric retrospective study on patients referred for cardiac mass assessment between 2006 and 2019, and analyzed the respective contribution of transesophageal echocardiography (TEE), cardiac computed tomography (CT), cardiac magnetic resonance (CMR) and

Identifiants

pubmed: 32040684
doi: 10.1007/s10554-020-01774-z
pii: 10.1007/s10554-020-01774-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

971-981

Références

J Cardiovasc Imaging. 2018 Jun;26(2):93-102
pubmed: 29971271
J Clin Pathol. 2007 Jan;60(1):27-34
pubmed: 17098886
J Nucl Med. 2012 Jun;53(6):856-63
pubmed: 22577239
Arch Pathol Lab Med. 1993 Oct;117(10):1027-31
pubmed: 8215825
Curr Treat Options Cardiovasc Med. 2019 Sep 5;21(10):55
pubmed: 31486926
Echocardiography. 2018 May;35(5):735-742
pubmed: 29790225
Herz. 2004 Nov;29(7):702-9
pubmed: 15580325
Mayo Clin Proc. 1991 Nov;66(11):1101-9
pubmed: 1943240
J Am Soc Echocardiogr. 1991 Jul-Aug;4(4):323-30
pubmed: 1910830
Dtsch Arztebl Int. 2014 Mar 21;111(12):205-11
pubmed: 24717305
Int J Cardiol. 2016 Jan 15;203:474-81
pubmed: 26551882
J Nucl Cardiol. 2019 Aug;26(4):1392-1413
pubmed: 31250324
Chest. 1993 May;103(5):1447-51
pubmed: 8486026
J Am Heart Assoc. 2019 Jan 8;8(1):e007829
pubmed: 30616453
Curr Treat Options Cardiovasc Med. 2018 Mar 20;20(4):29
pubmed: 29556752
Radiographics. 2000 Sep-Oct;20(5):1303-19
pubmed: 10992020

Auteurs

Maëva Lemasle (M)

Department of Cardiology, Rangueil University Hospital, Toulouse, France. mae.lemasle@orange.fr.
Cardiac Imaging Center, Toulouse University Hospital, Toulouse, France. mae.lemasle@orange.fr.
Heart Valve Center, Toulouse University Hospital, Toulouse, France. mae.lemasle@orange.fr.

Yoan Lavie Badie (Y)

Department of Cardiology, Rangueil University Hospital, Toulouse, France.
Cardiac Imaging Center, Toulouse University Hospital, Toulouse, France.
Heart Valve Center, Toulouse University Hospital, Toulouse, France.
Department of Nuclear Medicine, Toulouse University Hospital, Toulouse, France.

Eve Cariou (E)

Department of Cardiology, Rangueil University Hospital, Toulouse, France.
Cardiac Imaging Center, Toulouse University Hospital, Toulouse, France.
Heart Valve Center, Toulouse University Hospital, Toulouse, France.

Pauline Fournier (P)

Department of Cardiology, Rangueil University Hospital, Toulouse, France.
Cardiac Imaging Center, Toulouse University Hospital, Toulouse, France.
Heart Valve Center, Toulouse University Hospital, Toulouse, France.

Jean Porterie (J)

Department of Cardiology, Rangueil University Hospital, Toulouse, France.
Heart Valve Center, Toulouse University Hospital, Toulouse, France.
Medical School, Toulouse III Paul Sabatier University, Toulouse, France.

Hervé Rousseau (H)

Cardiac Imaging Center, Toulouse University Hospital, Toulouse, France.
Medical School, Toulouse III Paul Sabatier University, Toulouse, France.

Antoine Petermann (A)

Cardiac Imaging Center, Toulouse University Hospital, Toulouse, France.

Anne Hitzel (A)

Cardiac Imaging Center, Toulouse University Hospital, Toulouse, France.
Department of Nuclear Medicine, Toulouse University Hospital, Toulouse, France.
Medical School, Toulouse III Paul Sabatier University, Toulouse, France.

Didier Carrié (D)

Department of Cardiology, Rangueil University Hospital, Toulouse, France.
Cardiac Imaging Center, Toulouse University Hospital, Toulouse, France.
Heart Valve Center, Toulouse University Hospital, Toulouse, France.
Medical School, Toulouse III Paul Sabatier University, Toulouse, France.

Michel Galinier (M)

Department of Cardiology, Rangueil University Hospital, Toulouse, France.
Cardiac Imaging Center, Toulouse University Hospital, Toulouse, France.
Heart Valve Center, Toulouse University Hospital, Toulouse, France.
Medical School, Toulouse III Paul Sabatier University, Toulouse, France.

Bertrand Marcheix (B)

Department of Cardiology, Rangueil University Hospital, Toulouse, France.
Heart Valve Center, Toulouse University Hospital, Toulouse, France.
Medical School, Toulouse III Paul Sabatier University, Toulouse, France.

Olivier Lairez (O)

Department of Cardiology, Rangueil University Hospital, Toulouse, France.
Cardiac Imaging Center, Toulouse University Hospital, Toulouse, France.
Heart Valve Center, Toulouse University Hospital, Toulouse, France.
Department of Nuclear Medicine, Toulouse University Hospital, Toulouse, France.
Medical School, Toulouse III Paul Sabatier University, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH